RELIANCE interim data shows that long-term CAN is safe & effective in CAPS. Interestingly, investigators observed a trend toward updosing over standard dosing. Abs 0191 #ACR21 #RheumNow @RheumNow https://t.co/ik6dAEZjFf https://t.co/arqSEzuC6Q
Links:
Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients wi…
http://ow.ly/rEpy50Gqh3d
06-11-2021